Fluoroquinolones, Folic Acid Antagonists & Urinary Antiseptics Flashcards
Examples of fluoroquinolones
2G - Ciprofloxacin (oral, IV), Ofloxacin (oral)
3G - Levofloxacin (oral, IV)
4G - Gatifloxacin (topical - eyedrops)
Mechanism of action of fluoroquinolones
Inhibits DNA synthesis
- Blocks DNA gyrase - blocks relaxation of supercoiled DNA - blocks DNA replication
- Blocks topoisomerase - blocks separation of chromosomal DNA
PK of fluoroquinolones
- absorption is affected by Ca and other divalent cations
- well distributed, ofloxacin can penetrate CSF
- accumulate in macrophages & polymorphs in high conc & carried to site of infection
- cipro partially metabolized by CYP450 (liver)
- renally excreted, accumulation occurs in renal impairment
Spectrum of activity & uses of fluoroquinolones (5)
Broad spectrum - gram neg, gram pos, mycobacterium tb
Ciprofloxacin
- Traveller’s diarrhea/food poisoning (enterobac)
- Prostatitis (E coli)
- UTI
Levofloxacin
- CAP (S pneum unresponsive to macrolides/doxy)
- Pulm TB 2nd line
Toxicity of fluoroquinolones (5)
- GIT related
- CNS related
- Tendinitis in adults - rare - most commonly Achilles tendon, may lead to tendon rupture esp in older patients
- CDAD
- ECG - QT prolongation
Contraindications of fluoroquinolones (4)
- Pregnancy/breastfeeding
- Children/elderly
- Anti-arrhythmic drugs
- Epileptic
Drug interactions of fluoroquinolones (5)
- Ciprofloxacin + theophylline - decreases theophylline clearance - toxicity - tremors, nervousness, cardiac dysrhythmias, seizures
- NSAIDs - seizures
- Ciprofloxacin + anti-thrombotic (warfarin) - increased PT & risk of bleeding
- Ofloxacin/ciprofloxacin + Antacids - reduces bioavailability of fluoroquinolones
- Ciprofloxacin _ CYP450 inhibitors - increased levels of cipro
Examples of folic acid antagonists
- Sulphonamides - Sulphamethoxazole (SMZ) - oral
- Benzylpyrimidines - Trimethoprim (TMP) - oral, syrup
- Compound drugs - SMZ + TMP - Co-trimoxazole, trade names bactrim, septra - oral, IV, syrup
Mechanism of action of folic acid antagonists
- Competitive inhibition
- SMZ inhibits dihydropteroate synthetase
- TMP inhibits dihydrofolate reductase - Produces sequential block of folic acid synthesis req for DNA synthesis
Bactericidal
Mechanism of resistance of folic acid antagonists (3)
- Increased number of competing enzymes
- Decreased affinity for drugs
- Decreased permeability to drugs
PK of folic acid antagonists
- good oral bioavailability
- widely distributed, enters CSF, crosses placenta
- SMZ acetylated in the liver, TMP partially demethylated in liver
- excreted renally mainly by glomerular filtration
Spectrum of activity & uses of folic acid antagonists (3)
Aerobic gram pos & gram neg
- UTI
- Traveller’s Diarrhea
- Pneumonia
Toxicity of folic acid antagonists (4)
- Rash
- GIT related
- Glossitis, stomatitis
- Hematologic - pancytopenia with megaloblastic anemia
Contraindications of folic acid antagonists (3)
- Newborns/breastfeeding mothers - SMZ can displace bilirubin from albumin binding sites - cross immature BBB - damage brain & nerves
- Enhances antithrombotic effect of warfarin, increases methotrexate levels
- Increases half life of phenytoin by inhibiting its metab
- Give patients folinic acid (readily converted to tetrahydrofolic acid) to avoid folic acid deficiency
Mechanism of action of nitrofurantoin
Oral urinary antiseptic, eliminated renally, produces harmless brown discolouration in urine
- Microbes produce enzyme nitrofuran reductase - reduces drug to form highly reactive electrophilic intermediates
- Damages bacterial ribosomal proteins - inhibits protein synthesis